{"version":"1.0","type":"link","title":"Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.","author_name":"Nusawat C 외","author_url":"https://prs-insight.online/author/Nusawat%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96090","thumbnail_width":1200,"thumbnail_height":630}